Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Icodextrin
Drug ID BADD_D01124
Description Icodextrin is an iso-osmotic peritoneal dialysis solution containing glucose polymers. It is used primarily for ambulatory peritoneal dialysis (CAPD) of diabetic patients and automated peritoneal dialysis (APD) for patients with end-stage renal disease. It is injected as a solution into the peritoneal cavity. The drug is absorbed via convective transport via peritoneal lymphatic pathways.
Indications and Usage Used for continuous ambulatory peritoneal dialysis (CAPD) of diabetic patients or automated peritoneal dialysis (APD) for the management of end-stage renal disease.
Marketing Status approved; investigational
ATC Code Not Available
DrugBank ID DB00702
KEGG ID D03266
MeSH ID D000077607
PubChem ID 3517
TTD Drug ID D02YCH
NDC Product Code 66127-100
UNII 2NX48Z0A9G
Synonyms Icodextrin | Extraneal | Icodial
Chemical Information
Molecular Formula C8H8Cl2N4
CAS Registry Number 5051-62-7
SMILES C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Skin ulcer23.07.03.003; 24.04.03.007--
Swelling face08.01.03.100; 23.04.01.018; 10.01.05.018--Not Available
Syncope02.11.04.015; 24.06.02.012; 17.02.04.008--
Tachycardia02.03.02.007--Not Available
Tension19.06.02.005--Not Available
Thinking abnormal19.10.03.001; 17.02.05.023--Not Available
Thrombocytopenia01.08.01.002--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
Toxic epidermal necrolysis11.07.01.006; 10.01.01.006; 23.03.01.008; 12.03.01.015--
Upper respiratory tract infection22.07.03.011; 11.01.13.009--
Urticaria10.01.06.001; 23.04.02.001--
Vasculitis10.02.02.006; 24.12.04.027--
Vision blurred17.17.01.010; 06.02.06.007--
Vomiting07.01.07.003--
Weight decreased13.15.01.005--
Weight increased13.15.01.006--
Onychomadesis23.02.05.006--
Balance disorder08.01.03.081; 17.02.02.007--Not Available
Fluid imbalance14.05.01.003--Not Available
Infusion related reaction08.01.03.002; 12.02.05.009; 10.01.01.017--
Catheter site erythema23.03.06.014; 12.07.02.003; 08.02.02.003--Not Available
Catheter site inflammation12.07.02.010; 08.02.02.010--Not Available
Lymphatic disorder01.09.01.003--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Infusion site pain12.07.05.002; 08.02.05.014--Not Available
Hypertensive nephropathy24.08.05.003; 20.01.08.004--Not Available
Haemorrhage24.07.01.002--Not Available
Catheter site infection08.02.02.006; 12.07.02.006; 11.01.08.022--Not Available
Toxic skin eruption12.03.01.073; 23.03.05.003; 10.01.01.008--Not Available
Breast disorder21.05.04.004--Not Available
The 5th Page    First    Pre   5 6    Next   Last    Total 6 Pages